Log In
BCIQ
Print this Print this
 

SI-614

  Manage Alerts
Collapse Summary General Information
Company Seikagaku Corp.
DescriptionModified hyaluronate
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentPhase II/III
Standard IndicationDry eye
Indication DetailsTreat dry eye
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today